Adu Appiah-Kubi

Adu Appiah-Kubi

Auto-generated profile, based on publicly available information

Adu Appiah-Kubi

Department of Obstetrics and Gynaecology, School of Medicine, University of Health and Allied Sciences, Ho, Ghana

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2022 in Ghana Medical Journal
Verified
Journal Article
Open access
PDF file
AAAdu Appiah-Kubi
Adu Appiah-Kubi
TKThomas O. Konney
Thomas O. Konney
KAKwabena Amo-Antwi
Kwabena Amo-Antwi
ATAugustine Tawiah
Augustine Tawiah
MNMaxwell K. Nti
Maxwell K. Nti
ELEmma R. Lawrence
Emma R. Lawrence
Objective: To explore factors associated with late clinical presentation among Ghanaian women with cervical cancerDesign: This is a cross-sectional survey using a paper questionnaire.Setting: Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana.Participants: Participants were women presenting for cervical cancer care at KATH. Inclusion criteria were histo-logically diagnosed cervical cancer and age ≥18 years. The exclusion criteria was age <18. All women presenting from August 2018-August 2019 were recruited.Main outcome measures: The primary outcome was the proportion of participants presenting with late-stage cervical cancer, defined as stage II or higher.Results: Of 351 total participants, 33.6% were unemployed, 35.3% had no formal education, and 96.6% had an aver-age monthly income of less than five hundred Ghana cedis ($86 USD). Time from symptoms to seeing a doctor ranged from fewer than two weeks (16.0%) to more than twelve months (8.6%). Participants’ most common barrier in seeking healthcare was financial constraints (50.0%). Most participants presented at late-stage cervical cancer (95.2%, n=334), with only 4.8% (n=17) presenting at stage I. Of participants presenting with late-stage cervical cancer, the vast major-ity had never had a Papanicolaou (Pap) smear (99.1%) nor a recent gynecologic exam (99.3%). After adjusting for age, parity, and distance to a healthcare facility, a late-stage presentation was associated with lower income and living in a rural area.Conclusions: In Ghana, 95% of women with cervical cancer seek care at a late clinical stage, defined as stage II or greater, when the cancer is inoperable.

5 September 2022 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
ELEmma R. Lawrence
Emma R. Lawrence
AAAdu Appiah-Kubi
Adu Appiah-Kubi
HLHannah R. Lawrence
Hannah R. Lawrence
MLMaxine Y. Lui
Maxine Y. Lui
RORuth Owusu-Antwi
Ruth Owusu-Antwi
CMCheryl A. Moyer
Cheryl A. Moyer
Background: Maternal mortality has a multifaceted impact on families, especially in low- and middle-income countries, where rates of maternal mortality are high and resources can be lacking. The objective of this study was to explore the ways that maternal mortality influences the physical and emotional wellbeing, financial stability, and caregiving structure of families, and identifies sources of and gaps in support.Methods: Our study used a mixed-methods design. All maternal mortalities in an 18-month period at a tertiary hospital in Ghana were identified using death certificates. Participants were 51 family members (either husbands or other heads of households) in families affected by maternal mortality. A questionnaire assessed demographic characteristics and changes in family health, income, and family structure. Two validated scales assessing psychological wellbeing were administered: the Patient Health Questionnaire-9 and the Inventory of Complicated Grief. Semi-structured interviews were conducted to assess impact on family wellbeing.Results: Quantitative and qualitative results converged to highlight large, negative impacts of maternal mortality on four areas of family wellbeing: 1) mental health and emotional wellbeing; 2) physical health; 3) family structure; 4) financial stability and security. On the Patient Health Questionnaire-9, 54% (27/50) of participants reported elevated depressive symptoms, with 14% (7/50) of scores falling in the moderately severe or severe ranges. On the Inventory of Complicated Grief, 38% (19/50) exceeded the cutoff for significant impairment in functioning. Worsened family health was associated with greater complicated grief (b = 21.41,p = .004); there were no other significant predictors of depressive symptom severity or complicated grief. Effects on family health centered on concerns about the nutritional status and health of the surviving infant. Family structure was primarily affected by fracturing of the central family unit by sending children to live with relatives. Immense economic strain resulted from hospital bills, funeral expenses, and loss of income. The majority of participants received helpful support from their family (41/51, 80.4%), the community (32/51, 62.7%), and their religious institution (43/51, 84.3%); however, support often stopped soon after the death.Conclusions: Maternal mortality has profound negative impacts on families in Ghana. Impacts are experienced by husbands and heads of households, as well as surviving children. Both immediate and sustained support is needed for families following a maternal death, especially mental health and financial support.

18 June 2022 in AJOG Global Reports
Verified
Journal Article
Open access
SBSarah G. Bell
Sarah G. Bell
AAAdu Appiah-Kubi
Adu Appiah-Kubi
TKThomas O. Konney
Thomas O. Konney
ATAugustine Tawiah
Augustine Tawiah
SYSamuel Yost
Samuel Yost
ELEmma R. Lawrence
Emma R. Lawrence
Pain because of cervical cancer is a significant health issue globally, especially in women with advanced disease. However, little is known about unmet needs for pain control in low-resource settings where the burden of cervical cancer is the greatest. This study aimed to quantify the level of pain that women with cervical cancer in Ghana experience, explore attitudes toward pain and pain medications, and determine the barriers to adequate pain control. A cross-sectional survey was conducted on 100 adult women with a histopathologic diagnosis of cervical cancer presenting for care at Komfo Anokye Teaching Hospital in Ghana. In addition, a descriptive analysis was conducted among all participants and the subgroup of women who reported pain but did not report pain medication use. Among 100 participants with cervical cancer, the mean age was 59.5 years, and the median parity was 6.0 (interquartile range, 5.0–6.0); moreover, most participants presented with inoperable stage II or greater cervical cancer (99 of 100 [99%]). Of 100 participants, 80 (80%) had pain caused by their cervical cancer, with more than half (51 of 100 [51%]) rating their pain as a 3, 4, or 5 on a 5-point scale. Most participants reported pain significant enough to impact their sleep (58 of 99 [58.6%]) and their ability to carry out daily activities (54 of 100 [54%]). Furthermore, 55 of 100 participants (55%) took pain medications in the last week; however, only 5 of 54 participants (9.3%) reported complete improvement in their pain, and most participants (30 of 54 [55.6%]) felt they needed a stronger pain medication. Barriers to adequate pain control included the healthcare provider's focus on pain, with 14.1% of women reporting that their healthcare providers never asked about their pain (14 of 99 [14.1%]). In addition, participants’ attitudes toward pain control demonstrated that 34 of 95 participants (35.8%) believed that they should be able to tolerate their cervical cancer pain without medication. Among participants who ever took pain medication, 16 of 58 (27.6%) were bothered that they took pain medication, and 19 of 58 (32.7%) were concerned that they used too much medication. Most participants were able to afford (51 of 58 [88%]) and access (56 of 58 [96.6%]) pain medications and did not worry their supply would run out (56 of 58 [96.6%]). Most patients had significant pain because of cervical cancer, and many of them endorsed needing more pain medications than what they were prescribed. The etiologies of the unmet need for pain control included missed opportunities to discuss pain control at clinic visits and patients’ attitudes toward pain management. Financial and access barriers to obtaining pain medications were minimal.

1 September 2022
Verified
Journal Article
Closed access
ELEmma R. Lawrence
Emma R. Lawrence
SBSarah G. Bell
Sarah G. Bell
AAAdu Appiah-Kubi
Adu Appiah-Kubi
TKTom O. Konney
Tom O. Konney
ATAugustine Tawiah
Augustine Tawiah
SCSarah D. Compton
Sarah D. Compton

2 May 2023 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
AUAkaninyene Eseme Bernard Ubom
Akaninyene Eseme Bernard Ubom
SOSebastine Oiwoh
Sebastine Oiwoh
AAAkinyosoye Deji Ajiboye
Akinyosoye Deji Ajiboye
SNSolomon Nyeche
Solomon Nyeche
AAAdu Appiah‐Kubi
Adu Appiah‐Kubi
DODimie Ogoina
Dimie Ogoina

13 February 2023 in Reproductive, Female and Child Health
Verified
Journal Article
Open access
KZKatherine R. Zurales
Katherine R. Zurales
AAAdu Appiah‐Kubi
Adu Appiah‐Kubi
SBSarah G. Bell
Sarah G. Bell
TKThomas Konney
Thomas Konney
ATAugustine Tawiah
Augustine Tawiah
ELEmma R. Lawrence
Emma R. Lawrence
Objective: To explore knowledge about the human papillomavirus (HPV), HPV vaccination, barriers to vaccination and acceptance of the HPV vaccine in the highest‐risk and most‐impacted population in Ghana.Methods: A survey was administered to 100 women with histologically confirmed cervical cancer at a teaching hospital in Ghana.Results: Participants had a mean age of 59 (±14.3) years, 65.0% had a parity of five or higher and 89.0% had a monthly income less than 500 Ghana cedis ($63 USD). Seventy‐nine percent of participants had a diagnosis of stage III or greater cervical cancer. Only 8.0% had heard of HPV and 4.0% knew that HPV caused cervical cancer. Fifty‐five percent had not heard of vaccines, in general; of the remainder, the majority endorsed that vaccines, in general, were effective (89.0%) and safe (95.0%). No participants had received the HPV vaccine. After a brief education session, 94% believed the HPV vaccine was effective and 65.0% were categorised as having ‘high vaccine acceptance’ after responding ‘definitely yes’ to recommending the HPV vaccine to female relatives, male relatives and the community. There were no significant differences in demographic variables or cervical cancer disease characteristics between the ‘high vaccine acceptance’ and ‘some vaccine hesitancy’ groups.Conclusion: Although women with cervical cancer in Ghana have low awareness of HPV and HPV vaccination, they demonstrate high vaccine acceptability and low hesitancy.